» Articles » PMID: 25465468

Mitochondrial Dysfunction and Tissue Injury by Alcohol, High Fat, Nonalcoholic Substances and Pathological Conditions Through Post-translational Protein Modifications

Overview
Journal Redox Biol
Date 2014 Dec 4
PMID 25465468
Citations 60
Authors
Affiliations
Soon will be listed here.
Abstract

Mitochondria are critically important in providing cellular energy ATP as well as their involvement in anti-oxidant defense, fat oxidation, intermediary metabolism and cell death processes. It is well-established that mitochondrial functions are suppressed when living cells or organisms are exposed to potentially toxic agents including alcohol, high fat diets, smoking and certain drugs or in many pathophysiological states through increased levels of oxidative/nitrative stress. Under elevated nitroxidative stress, cellular macromolecules proteins, DNA, and lipids can undergo different oxidative modifications, leading to disruption of their normal, sometimes critical, physiological functions. Recent reports also indicated that many mitochondrial proteins are modified via various post-translation modifications (PTMs) and primarily inactivated. Because of the recently-emerging information, in this review, we specifically focus on the mechanisms and roles of five major PTMs (namely oxidation, nitration, phosphorylation, acetylation, and adduct formation with lipid-peroxides, reactive metabolites, or advanced glycation end products) in experimental models of alcoholic and nonalcoholic fatty liver disease as well as acute hepatic injury caused by toxic compounds. We also highlight the role of the ethanol-inducible cytochrome P450-2E1 (CYP2E1) in some of these PTM changes. Finally, we discuss translational research opportunities with natural and/or synthetic anti-oxidants, which can prevent or delay the onset of mitochondrial dysfunction, fat accumulation and tissue injury.

Citing Articles

Newer Therapeutic Approaches in Treating Alzheimer's Disease: A Comprehensive Review.

Reddi Sree R, Kalyan M, Anand N, Mani S, Gorantla V, Sakharkar M ACS Omega. 2025; 10(6):5148-5171.

PMID: 39989768 PMC: 11840625. DOI: 10.1021/acsomega.4c05527.


Peroxisome proliferator-activated receptor γ coactivator 1α maintains NAD bioavailability protecting against steatohepatitis.

Shen W, Wan X, Hou J, Liu Z, Mao G, Xu X Life Med. 2025; 1(2):207-220.

PMID: 39871927 PMC: 11749270. DOI: 10.1093/lifemedi/lnac031.


Crocin and gallic acid attenuate ethanol-induced mitochondrial dysfunction via suppression of ROS formation and inhibition of mitochondrial swelling in pancreatic mitochondria.

Salimi A, Khezri S, Amani M, Badrinezhad N, Hosseiny S, Saadati R Mol Cell Biochem. 2025; .

PMID: 39754004 DOI: 10.1007/s11010-024-05180-0.


Transcriptomic and proteomic sequencing unveils the role of vitamin D and metabolic flux shifts in the induction of human hepatic organoids.

Zhang S, Liu L, Li X, Zhou T, Shi Q, Li D Stem Cell Res Ther. 2024; 15(1):478.

PMID: 39696644 PMC: 11657659. DOI: 10.1186/s13287-024-04101-8.


Gut Microbiota and Metabolic Dysfunction-Associated Steatotic Liver Disease.

Scarpellini E, Scarcella M, Tack J, Scarlata G, Zanetti M, Abenavoli L Antioxidants (Basel). 2024; 13(11).

PMID: 39594528 PMC: 11591341. DOI: 10.3390/antiox13111386.


References
1.
Cheshchevik V, Lapshina E, Dremza I, Zabrodskaya S, Reiter R, Prokopchik N . Rat liver mitochondrial damage under acute or chronic carbon tetrachloride-induced intoxication: protection by melatonin and cranberry flavonoids. Toxicol Appl Pharmacol. 2012; 261(3):271-9. DOI: 10.1016/j.taap.2012.04.007. View

2.
Pagliarini D, Calvo S, Chang B, Sheth S, Vafai S, Ong S . A mitochondrial protein compendium elucidates complex I disease biology. Cell. 2008; 134(1):112-23. PMC: 2778844. DOI: 10.1016/j.cell.2008.06.016. View

3.
Jauslin M, Meier T, Smith R, Murphy M . Mitochondria-targeted antioxidants protect Friedreich Ataxia fibroblasts from endogenous oxidative stress more effectively than untargeted antioxidants. FASEB J. 2003; 17(13):1972-4. DOI: 10.1096/fj.03-0240fje. View

4.
Schattenberg J, Wang Y, Singh R, Rigoli R, Czaja M . Hepatocyte CYP2E1 overexpression and steatohepatitis lead to impaired hepatic insulin signaling. J Biol Chem. 2005; 280(11):9887-94. DOI: 10.1074/jbc.M410310200. View

5.
Forsyth C, Voigt R, Shaikh M, Tang Y, Cederbaum A, Turek F . Role for intestinal CYP2E1 in alcohol-induced circadian gene-mediated intestinal hyperpermeability. Am J Physiol Gastrointest Liver Physiol. 2013; 305(2):G185-95. PMC: 3725682. DOI: 10.1152/ajpgi.00354.2012. View